Sequential re-rating: management describes the same offering landing bigger the second and third time around
The model's full reasoning — Q4 2023 call → NOWe need to determine if management describes successive engagements of the same kind coming in at progressively larger size. Look for any statement about deals, orders, contracts, projects, customers, sites, or programs being individually bigger, broader, or longer than before. Scan the transcript. Duncan Bates discusses various topics: sales, dealer side, park side, land development, workforce housing, etc. He mentions "We are quoting and winning small orders" for workforce housing. That suggests small orders, not larger. He talks about new dealers signed, but not size. He mentions "interest from new dealers" and "signed up more new dealers this month than any other month" - that's volume, not size per dealer. He mentions "heritage stores are on track for the best sales month" - again volume. He talks about land development: "completing Phase 1 of our Del Val Bastrop County project" - that's a project, but not about increasing size of engagements. He mentions "we are exploring opportunities to add financing products" - not about size. He mentions "we started to see an interesting trend as traditional community developers and investors started taking delivery of small HUD units and tiny homes for RV parks" - that's smaller units, not larger. He mentions "We have held pricing levels and held production levels" - no size escalation. He mentions "we are seeing the impact of higher interest rates on the parts side" - not about size. No mention of deals coming in at progressively larger size. In fact, he mentions smaller homes, smaller orders. So answer NO. Check if any analyst asks about that? No. So answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
AKYA · Q2 2023 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing a clear pattern of escalating project sizes in the translational/clinical space. Brian notes a migration from exploratory studies (reasonable size) to larger retrospective studies and even larger retrospective-prospective ongoing clinical studies, with projects moving "further and further downstream.
ASAN · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES Management describes exactly this pattern. Dustin notes the company is “closing larger deals and expanding seats across departments and geographies quickly in large organizations,” and that the growth in the >$50k cohort “reflected an acceleration in our largest enterprise customers.
SGRY · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing exactly this pattern for physician recruiting cohorts. Wayne notes that the 2022 cohorts are “no exception to this trend, bringing more cases with a higher overall net revenue per case than our 2021 cohorts did in the same period last year.